On 30 May 2016
Sharon Bio-Medicine will hold a meeting of the Board of Directors of the Company on 30 May 2016 to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and nine months period ended 31 March, 2016.Powered by Capital Market - Live News
